The bill establishes a new section, 409.9067, in the Florida Statutes, which mandates that drug manufacturers, pharmacy benefits managers, and drug wholesalers or distributors sell specified drugs to Medicaid pharmacies at discounted prices under the 340B Drug Pricing Program. Specifically, drug manufacturers are required to sell these drugs at the 340B discounted price if they are included on the Medicaid preferred drug list and are covered under the 340B program. Additionally, if the discounted price exceeds the state Medicaid negotiated price, manufacturers must pay a rebate to the state. Pharmacy benefits managers must also compensate Medicaid pharmacies at the 340B discounted price plus a professional dispensing fee for eligible drugs.

Furthermore, drug wholesalers and distributors are prohibited from altering their current pricing models in a way that would exempt these drugs from the established pricing. The bill restricts Medicaid pharmacies from selling the specified drugs at the 340B discounted prices to anyone other than Medicaid recipients. The provisions of this act are set to take effect on January 1, 2026.